Col N - Search Results

1

Should We Use the IMPACT-Model for the Outcome Prognostication of TBI Patients? A Qualitative Study Assessing Physicians' Perceptions.

Moskowitz J, Quinn T, Khan MW, Shutter L, Goldberg R, Col N, Mazor KM, Muehlschlegel S. Moskowitz J, et al. Among authors: col n. MDM Policy Pract. 2018 Mar 26;3(1):2381468318757987. doi: 10.1177/2381468318757987. eCollection 2018 Jan-Jun. MDM Policy Pract. 2018. PMID: 30288437 Free PMC article.

2

Questioning the accuracy of a recent review of osteoporosis medications.

Kuhl LN, Ettinger B, Rosen CJ, Col NF. Kuhl LN, et al. Among authors: col nf. Ann Intern Med. 2009 Mar 17;150(6):423-4; author reply 424-5. doi: 10.7326/0003-4819-150-6-200903170-00015. Ann Intern Med. 2009. PMID: 19293078 No abstract available.

3

Comments and response on the USPSTF recommendation on screening for breast cancer.

Col NF, Hansen MH, Fischhoff B, Pauker SG. Col NF, et al. Ann Intern Med. 2010 Apr 20;152(8):542; author reply 543-4. doi: 10.7326/0003-4819-152-8-201004200-00206. Epub 2010 Feb 15. Ann Intern Med. 2010. PMID: 20157100 Free article. No abstract available.

4

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.

Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Surks MI, et al. JAMA. 2004 Jan 14;291(2):228-38. doi: 10.1001/jama.291.2.228. JAMA. 2004. PMID: 14722150 Review.

5

Subclinical thyroid disease: clinical applications.

Col NF, Surks MI, Daniels GH. Col NF, et al. JAMA. 2004 Jan 14;291(2):239-43. doi: 10.1001/jama.291.2.239. JAMA. 2004. PMID: 14722151

6

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.

Meadows ES, Mitchell BD, Bolge SC, Johnston JA, Col NF. Meadows ES, et al. BMC Womens Health. 2012 Jan 6;12:1. doi: 10.1186/1472-6874-12-1. BMC Womens Health. 2012. PMID: 22225919 Free PMC article.

7

Does aspirin consumption affect the presentation or severity of acute myocardial infarction?

Col NF, Yarzbski J, Gore JM, Alpert JS, Goldberg RJ. Col NF, et al. Arch Intern Med. 1995 Jul 10;155(13):1386-9. Arch Intern Med. 1995. PMID: 7794087

8

Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy.

Col NF, Gurwitz JH, Alpert JS, Goldberg RJ. Col NF, et al. Am J Cardiol. 1994 Jan 15;73(2):149-57. doi: 10.1016/0002-9149(94)90206-2. Am J Cardiol. 1994. PMID: 8296736

9

The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study.

Col NF, McLaughlin TJ, Soumerai SB, Hosmer DW Jr, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Col NF, et al. Arch Intern Med. 1996 Jan 8;156(1):54-60. Arch Intern Med. 1996. PMID: 8526697

10

Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective.

Yarzebski J, Col N, Pagley P, Savageau J, Gore J, Goldberg R. Yarzebski J, et al. Among authors: col n. Am Heart J. 1996 Jan;131(1):43-50. doi: 10.1016/s0002-8703(96)90049-6. Am Heart J. 1996. PMID: 8554018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters